SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Morepen Laboratories - Quaterly Results

12 Aug 2024 Evaluate
The quarter ended June 2024 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 3856.43 millions.The Net Profit of the company reported a remarkable increase of 121.15% to Rs. 350.50  millions  from Rs. 158.49 millions in previous same quarter.Operating Profit saw a handsome growth to 516.82 millions from 268.87 millions in the quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 3856.43 3691.03 4.48 3856.43 3691.03 4.48 15375.94 13388.83 14.84
Other Income 30.72 20.84 47.41 30.72 20.84 47.41 125.66 57.59 118.20
PBIDT 516.82 268.87 92.22 516.82 268.87 92.22 1743.84 830.29 110.03
Interest 10.44 2.83 268.90 10.44 2.83 268.90 35.09 19.81 77.13
PBDT 506.38 266.04 90.34 506.38 266.04 90.34 1708.75 810.48 110.83
Depreciation 35.90 48.93 -26.63 35.90 48.93 -26.63 219.00 180.06 21.63
PBT 470.48 217.11 116.70 470.48 217.11 116.70 1489.75 630.42 136.31
TAX 119.98 58.62 104.67 119.98 58.62 104.67 380.40 167.99 126.44
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -4.36 2.03 -314.78
PAT 350.50 158.49 121.15 350.50 158.49 121.15 1109.35 462.43 139.90
Equity 1022.27 1022.27 0.00 1022.27 1022.27 0.00 1022.27 1022.27 0.00
PBIDTM(%) 13.40 7.28 83.98 13.40 7.28 83.98 11.34 6.20 82.88

Morepen Laboratories Share Price

41.92 0.79 (1.92%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×